Chiral bicyclic gamma-butyrolactone compound and application thereof

A butyrolactone and compound technology, applied in the field of chiral bicyclic γ-butyrolactone compounds, can solve the problems of complex synthesis steps, no absolute configuration of products and specific examples, etc.

Pending Publication Date: 2022-03-08
SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

For example, the Chinese invention patent CN111138443A "A Preparation Method for Total Synthesis of 4'-Demethyl Epipodophyllotoxin" discloses a process method of an antineoplastic drug wooden box, which relates to a preparation method of epipodophyllotoxin: using Syringaldehyde is used as an initial material to react with 4-vinyl dihydrofuran-2-one to obtain an intermediate, and the synthesis method is complicated
[0005] In the oral report "Reactions Based on Furanones: Chiral Diprimary Amines Catalyzed Asymmetric D-A Reaction of Furanones with α, β-Unsaturated Ketones" previously reported by the inventors, it was proposed that furanones and α, β-unsaturated Saturated ketones undergo asymmetric reactions, but there are no absolute configurations and specific examples of previously reported products in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Chiral bicyclic gamma-butyrolactone compound and application thereof
  • Chiral bicyclic gamma-butyrolactone compound and application thereof
  • Chiral bicyclic gamma-butyrolactone compound and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0032] In order to make the object, technical solution and advantages of the present invention clearer, the present invention will be further described in detail below in combination with specific embodiments and with reference to the accompanying drawings. It should be understood that these descriptions are exemplary only, and are not intended to limit the scope of the present invention. Also, in the following description, descriptions of well-known structures and techniques are omitted to avoid unnecessarily obscuring the concept of the present invention.

[0033] The chiral diprimary amine catalyst structural formula of the present invention is:

[0034]

[0035] 1. Compound 3aa: take catalyst (1S,2S)-1,2-diphenylethylenediamine (0.05mmol) and N-Boc-L-Phg (0.05mmol) acidic additive and dissolve in solvent isopropanol (2.0mL ), pre-reacted for 15 minutes, added 1a (0.25mmol) and 2aa (0.5mmol) to the system, stirred at room temperature for 14 days, after the reaction was ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a chiral bicyclic gamma-butyrolactone compound and application thereof, the chiral bicyclic gamma-butyrolactone compound is a main skeleton of many compounds and drug molecules, and is an important active intermediate, for example, a natural product podophyllotoxin and a derivative thereof are widely applied to clinical treatment as an antitumor drug; the vorapaxar sulfate serving as a marketed drug is also used as an initiative oral PAR-1 inhibitor. According to the preparation method disclosed by the invention, through double Michael addition reaction of gamma-dimethyl furanone and alpha, beta-unsaturated ketone catalyzed by (1S, 2S)-1, 2-diphenylethylenediamine, functional products are rapidly obtained through one-step reaction, the yield is as high as 80%, and the stereoselectivity is gt; the chiral dicyclic gamma-butyrolactone compound with a specific molecular weight of 20: 1 and a relatively high er value is prepared, then the chiral dicyclic gamma-butyrolactone compound disclosed by the invention is subjected to a cell viability test, and the tested compound has a certain effect of inhibiting tumor cell viability on U87MG, HCT116, SH-SY-5Y, Kyse-30, MV4-1 and MCF-7 cell lines.

Description

technical field [0001] The invention belongs to the field of synthesis of medical compounds, in particular to a chiral bicyclic γ-butyrolactone compound and its application. Background technique [0002] Chiral bicyclic γ-butyrolactone compounds are the main skeleton of many terpenoids and drug molecules, such as itoposide and teniposide, which are already on the market, as topoisomerase II inhibitors, have antitumor Pharmacological effects; Vorapaxar sulfate is a first-in-class protein kinase receptor 1 antagonist, which is an antithrombotic drug for antiplatelet agents; there are other natural products such as podophyllotoxin and its analogs and heliolide compounds with various biological activities. Therefore, bicyclic γ-butyrolactone compounds with multiple chiral centers widely exist in various terpenoids and drug molecules with biological activity. It has been reported in the literature that α,β-unsaturated ketones react with nitroalkenes, α,β-unsaturated ketones, α,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07D307/88C07D409/04C07D307/94A61P35/00A61P35/02
CPCC07D307/88C07D409/04C07D307/94A61P35/00A61P35/02
Inventor 白著双张蔷孙捷王晓静魏晨润卞宇涵杜成林朱文宁臧德进
Owner SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products